Ir para o conteúdo principal

Novo Integrated Sciences (NYSE: NVOS) — Perfil da empresa, notícias e dados financeiros

Logo de Novo Integrated Sciences
NVOS Novo Integrated Sciences
Novo Integrated Sciences primary media
Perfil da empresa

Novo Integrated Sciences

Novo Integrated Sciences (NASDAQ:NVOS) is a company deeply invested in delivering innovative healthcare therapies and services. With a focus on multidisciplinary primary care, Novo is revolutionizing the way healthcare is delivered by integrating technology with medical and wellness specialties to provide accessible and holistic care solutions. The company operates through a mix of direct clinical services, digital health platforms, and technological advancements, aiming to bridge the gap between traditional medical care and advanced health innovations. Novo's projects include expanding its telemedicine services, developing new healthcare technologies, and increasing its market presence through strategic acquisitions. The objective is to create a seamless, patient-centered healthcare experience that is both efficient and effective, catering to the diverse needs of communities across various regions.

Resumo

Public USParticipação acionária
2000Ano de fundação
179Funcionários
Bellevue, United StatesSede
Carregando mapa...
Presença global

Operações

Todos os locais
Bellevue, US

Produtos e/ou serviços de Novo Integrated Sciences

  • Multidisciplinary primary healthcare services, integrating medical and wellness care.
  • Telemedicine and digital health platforms, connecting patients with healthcare providers.
  • Advanced diagnostic assessments, including biomechanical and neurocognitive testing.
  • Custom orthotics and prosthetics manufacturing, focusing on personalized patient care.
  • Pharmaceutical solutions, emphasizing on prescribing and patient management.
  • Educational support services for healthcare professionals, enhancing clinical proficiency.

equipe executiva do Novo Integrated Sciences

  • Mr. Robert MattacchioneChairman of the Board & CEO
  • Mr. Christopher Mehlin DavidCOO & Director
  • Mr. Vivek Sethi C.A., CPAPrincipal Financial Officer & Principal Accounting Officer
  • Dr. Joseph M. Chalil FACHE, M.B.A., M.D.Chief Medical Officer

Principais indicadores financeiros

Resultados divulgados pela Novo Integrated Sciences.

Receita e lucro anuais da Novo Integrated Sciences
Fim do ano fiscalReceitaResultado operacionalLucro líquido
13,3 mi-8,3 mi-16,1 mi
12,6 mi-8,6 mi-13,2 mi
11,7 mi-25 mi-33 mi
9,3 mi-4,3 mi-4,5 mi